Multiple system atrophy (MSA) is a progressive disorder with limited treatment options. However, recent research has yielded promising insights into new therapeutic approaches. Current efforts centers on addressing the underlying causes of MSA. One avenue under investigation involves drug-based interventions to modulate the activity of specific si